The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry

Background. The relative rarity and diversity of fibrotic interstitial lung disease (ILD) have made it challenging to study these diseases in single-centre cohorts. Here we describe formation of a multicentre Canadian registry that is needed to describe the outcomes of fibrotic ILD and to enable det...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Canadian Respiratory Journal
المؤلفون الرئيسيون:	Christopher J. Ryerson, Benjamin Tan, Charlene D. Fell, Hélène Manganas, Shane Shapera, Shikha Mittoo, Mohsen Sadatsafavi, Teresa To, Andrea Gershon, Jolene H. Fisher, Kerri A. Johannson, Nathan Hambly, Nasreen Khalil, Theodore K. Marras, Julie Morisset, Pearce G. Wilcox, Andrew J. Halayko, Mohammad Adil Khan, Martin Kolb
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Wiley 2016-01-01
الوصول للمادة أونلاين:	http://dx.doi.org/10.1155/2016/3562923

مواد مشابهة

Diagnostic Disparity of Previous and Revised American Thoracic Society Guidelines for Idiopathic Pulmonary Fibrosis
حسب: Lee Fidler, وآخرون
منشور في: (2015-01-01)

Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
حسب: Maria S. Nashatyreva, وآخرون
منشور في: (2023-01-01)

Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry
حسب: Craig S Conoscenti, وآخرون
منشور في: (2020-09-01)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
حسب: Lee Fidler, وآخرون
منشور في: (2015-01-01)

Idiopathic Pulmonary Fibrosis Registry China study (PORTRAY): protocol for a prospective, multicentre registry study
حسب: Ling Zhao, وآخرون
منشور في: (2020-11-01)

The world is not enough – the value of increasing registry data in idiopathic pulmonary fibrosis
حسب: C. C. Moor, وآخرون
منشور في: (2020-05-01)

Russian Registry of Idiopathic Pulmonary Fibrosis: Clinical Features, Treatment Management, and Outcomes
حسب: Svetlana Chikina, وآخرون
منشور في: (2023-02-01)

Design and baseline characteristics of the ILD-PRO registry in patients with progressive pulmonary fibrosis
حسب: L Jason Lobo, وآخرون
منشور في: (2024-09-01)

Impact of Pirfenidone on Patient-Reported Outcomes in Patients With Idiopathic Pulmonary Fibrosis From the Pulmonary Fibrosis Foundation Patient RegistryTake-home Points
حسب: Mohleen Kang, MD, MS, وآخرون
منشور في: (2024-12-01)

Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
حسب: Ross Summer, وآخرون
منشور في: (2024-01-01)

The impact of antifibrotic use on long-term clinical outcomes in the pulmonary fibrosis foundation registry
حسب: Cathryn T. Lee, وآخرون
منشور في: (2024-06-01)

Systematic review of content and quality of idiopathic pulmonary fibrosis review articles
حسب: Kathryn M. Milne, وآخرون
منشور في: (2018-12-01)

Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry
حسب: Jamie L. Todd, وآخرون
منشور في: (2019-10-01)

Factors associated with listing for lung transplantation in IPF patients: An analysis of the pulmonary fibrosis foundation registry
حسب: Christopher S. King, وآخرون
منشور في: (2023-08-01)

Clinical Characteristics and Survival of Patients with Idiopathic Pulmonary Fibrosis: Analysis of the Serbian Cohort from the EMPIRE Registry
حسب: Sanja Dimic-Janjic, وآخرون
منشور في: (2025-08-01)

Role of antifibrotics in progressive pulmonary fibrosis associated to autoimmune diseases: multicenter study from NEREA registry
حسب: Maria Asuncion Nieto, وآخرون
منشور في: (2025-07-01)

Comorbidities in the idiopathic pulmonary fibrosis and progressive pulmonary fibrosis trial population: a systematic review and meta-analysis
حسب: Tyson M. Walters, وآخرون
منشور في: (2025-03-01)

Extent of lung fibrosis is of greater prognostic importance than HRCT pattern in patients with progressive pulmonary fibrosis: data from the ILD-PRO registry
حسب: Aparna C. Swaminathan, وآخرون
منشور في: (2025-02-01)

Exacerbation of Pulmonary Fibrosis Following Single Lung Transplantation
حسب: Dawei Yang, وآخرون
منشور في: (2012-01-01)

Neighbourhood disadvantage impacts on pulmonary function in patients with sarcoidosis
حسب: Gillian C. Goobie, وآخرون
منشور في: (2022-10-01)

CPAnet Registry—An International Chronic Pulmonary Aspergillosis Registry
حسب: Christian B. Laursen, وآخرون
منشور في: (2020-06-01)

INFORMATION SYSTEM FOR REGISTRY OF PATIENTS WITH CYSTIC FIBROSIS
حسب: N. H. Horovenko, وآخرون
منشور في: (2015-05-01)

The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry
حسب: Marianna Štefániková, وآخرون
منشور في: (2023-05-01)

Vascular involvement in idiopathic pulmonary fibrosis
حسب: Michele Mondoni, وآخرون
منشور في: (2024-11-01)

Comparison of interstitial lung disease diagnoses in urban and rural areas among participants in the pulmonary fibrosis foundation patient registry
حسب: Anne E.F. Dimmock, وآخرون
منشور في: (2025-02-01)

Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry
حسب: Laurie Snyder, وآخرون
منشور في: (2019-05-01)

Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
حسب: Katerina Antoniou, وآخرون
منشور في: (2020-01-01)

Cystic Fibrosis Patient Registries: Domestic and Foreign Experience
حسب: Dmitry A. Andreev, وآخرون
منشور في: (2017-08-01)

Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study
حسب: Athol U. Wells, وآخرون
منشور في: (2024-12-01)

Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries – a real-world study from Finland
حسب: Jaana Kaunisto, وآخرون
منشور في: (2023-09-01)

Validating the Data Completeness and Accuracy of the Canadian Cystic Fibrosis Registry
حسب: Ranjani Somayaji, وآخرون
منشور في: (2025-01-01)

Respiratory oscillometry with CT image analysis in idiopathic pulmonary fibrosis following single lung transplant
حسب: Joyce K.Y. Wu, وآخرون
منشور في: (2024-01-01)

Isoniazid and Pulmonary Fibrosis
حسب: Chae Uk Chung, وآخرون
منشور في: (2015-01-01)

Idiopathic pulmonary fibrosis
حسب: Noble Paul W, وآخرون
منشور في: (2008-03-01)

Autophagy, Apoptosis, the Unfolded Protein Response, and Lung Function in Idiopathic Pulmonary Fibrosis
حسب: Pawan Sharma, وآخرون
منشور في: (2021-06-01)

Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
حسب: Boyang Zheng, وآخرون
منشور في: (2023-04-01)

Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis
حسب: Roxana-Elena Cîrjaliu, وآخرون
منشور في: (2023-06-01)

Management of Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
حسب: Abdullah Rashed Alharbi
منشور في: (2024-10-01)

Current Status of Cystic Fibrosis in Türkiye: Data from the National Registry
حسب: Dilber Ademhan Tural, وآخرون
منشور في: (2025-09-01)

The Diagnosis of Cystic Fibrosis in Adult Age. Data from the Italian Registry
حسب: Rita Padoan, وآخرون
منشور في: (2021-02-01)